Pages that link to "Q27473340"
Jump to navigation
Jump to search
The following pages link to Persistent Replication of Hepatitis C Virus Replicons Expressing the -Lactamase Reporter in Subpopulations of Highly Permissive Huh7 Cells (Q27473340):
Displaying 49 items.
- New hepatitis C virus drug discovery strategies and model systems (Q26851159) (← links)
- Development of a cell-based high-throughput specificity screen using a hepatitis C virus-bovine viral diarrhea virus dual replicon assay. (Q27469439) (← links)
- Replication fitness and NS5B drug sensitivity of diverse hepatitis C virus isolates characterized by using a transient replication assay (Q27469483) (← links)
- Dissecting the interferon-induced inhibition of hepatitis C virus replication by using a novel host cell line (Q27472675) (← links)
- Detection of anti-hepatitis C virus effects of interferon and ribavirin by a sensitive replicon system (Q27472717) (← links)
- Effect of cell growth on hepatitis C virus (HCV) replication and a mechanism of cell confluence-based inhibition of HCV RNA and protein expression (Q27472822) (← links)
- Novel Robust Hepatitis C Virus Mouse Efficacy Model (Q27477521) (← links)
- Replication and IRES-Dependent Translation Are Both Affected by Core Coding Sequences in Subgenomic GB Virus B Replicons (Q27477667) (← links)
- Superinfection Exclusion in Cells Infected with Hepatitis C Virus (Q27478378) (← links)
- Hep3B Human Hepatoma Cells Support Replication of the Wild-Type and a 5'-End Deletion Mutant GB Virus B Replicon (Q27486895) (← links)
- Selection of an optimal RNA transfection reagent and comparison to electroporation for the delivery of viral RNA (Q27488384) (← links)
- Hepatitis C virus replicons: dinosaurs still in business? (Q27488905) (← links)
- Development of a Cell-Based Hepatitis C Virus Infection Fluorescent Resonance Energy Transfer Assay for High-Throughput Antiviral Compound Screening (Q27490187) (← links)
- Novel insights into hepatitis C virus replication and persistence (Q29620681) (← links)
- Unexpected host range of hepatitis C virus replicons. (Q30339086) (← links)
- Insertion of green fluorescent protein into nonstructural protein 5A allows direct visualization of functional hepatitis C virus replication complexes (Q33204253) (← links)
- Identification of human kinases involved in hepatitis C virus replication by small interference RNA library screening. (Q33303326) (← links)
- Evaluation of compound activity against hepatitis C virus in replicon systems (Q34147312) (← links)
- Hepatitis C virus experimental model systems and antiviral drug research (Q34235286) (← links)
- Interferon lambda: opportunities, risks, and uncertainties in the fight against HCV. (Q34433087) (← links)
- Hepatitis C virus molecular clones and their replication capacity in vivo and in cell culture (Q34618241) (← links)
- Survivin-targeting Artificial MicroRNAs Mediated by Adenovirus Suppress Tumor Activity in Cancer Cells and Xenograft Models (Q35694238) (← links)
- Hepatitis C drug discovery: in vitro and in vivo systems and drugs in the pipeline (Q35917417) (← links)
- Replicon cell culture system as a valuable tool in antiviral drug discovery against hepatitis C virus (Q36058642) (← links)
- Hepatitis C virus comes full circle: production of recombinant infectious virus in tissue culture (Q36326835) (← links)
- Recent contributions of in vitro models to our understanding of hepatitis C virus life cycle (Q36933791) (← links)
- Cutting the gordian knot-development and biological relevance of hepatitis C virus cell culture systems (Q37201846) (← links)
- Conventional protein kinase C inhibition prevents alpha interferon-mediated hepatitis C virus replicon clearance by impairing STAT activation (Q37596530) (← links)
- Turning hepatitis C into a real virus (Q37891074) (← links)
- Tricistronic hepatitis C virus subgenomic replicon expressing double transgenes (Q38922859) (← links)
- Novel hepatitis C virus reporter replicon cell lines enable efficient antiviral screening against genotype 1a (Q39697713) (← links)
- A new living cell-based assay system for monitoring genome-length hepatitis C virus RNA replication (Q39964799) (← links)
- Mutations of the Hepatitis C virus protein NS4B on either side of the ER membrane affect the efficiency of subgenomic replicons (Q40261915) (← links)
- Reduction of hepatitis C virus NS5A hyperphosphorylation by selective inhibition of cellular kinases activates viral RNA replication in cell culture (Q40273957) (← links)
- Activation of Vgamma9Vdelta2 T cells by non-peptidic antigens induces the inhibition of subgenomic HCV replication (Q40339062) (← links)
- Hepatitis C virus subgenomic replicons in the human embryonic kidney 293 cell line (Q40377218) (← links)
- Replication of a novel subgenomic HCV genotype 1a replicon expressing a puromycin resistance gene in Huh-7 cells. (Q40459105) (← links)
- Characterization of resistance to non-obligate chain-terminating ribonucleoside analogs that inhibit hepatitis C virus replication in vitro (Q40550747) (← links)
- Sequence requirements for the development of a chimeric HCV replicon system (Q40578897) (← links)
- Effect of interaction between hepatitis C virus NS5A and NS5B on hepatitis C virus RNA replication with the hepatitis C virus replicon (Q40584601) (← links)
- Ralf Bartenschlager, Charles Rice, and Michael Sofia are honored with the 2016 Lasker~DeBakey Clinical Medical Research Award (Q42373783) (← links)
- An NS3 serine protease inhibitor abrogates replication of subgenomic hepatitis C virus RNA. (Q43049197) (← links)
- Identification of a key determinant of hepatitis C virus cell culture adaptation in domain II of NS3 helicase (Q43049435) (← links)
- Subgenomic HCV RNA replication and its localization in the nucleus of the infected cells (Q43064823) (← links)
- Engineered Livers for Infectious Diseases (Q47555660) (← links)
- Hepatitis C virus: Morphogenesis, infection and therapy. (Q52661702) (← links)
- Hepatitis C virus cell culture models: an encomium on basic research paving the road to therapy development (Q57295205) (← links)
- The remarkable history of the hepatitis C virus (Q90283971) (← links)
- HCV Replicon Systems: Workhorses of Drug Discovery and Resistance (Q97885926) (← links)